MMRGlobal announced that it has received a new patent from the United States Patent and Trademark Office entitled Electronic Health Records in Clinical Trials. The newly issued patent, U.S. Patent No. 8,775,212, opens the door to completely new revenue generating opportunities for the company through sales and licensing of MMR's Personal Health Record products and services and other patented intellectual property to Contract Research Organizations and pharmaceutical companies conducting clinical trials.

According to ClinicalTrials.gov, there are currently 170,766 studies occurring in all 50 states and in 187 countries being conducted by numerous CROs, universities and pharmaceutical companies. CROs, Big Pharma and pharmaceutical start-ups are consistently looking for ways to reduce costs and speed up the clinical trial process. MMR's products, services and patented IP are designed to help reduce trial costs and shorten trial times.

Accordingly, MMR plans on providing access to its Patented IP and products and services in consideration of traditional sales and licensing agreements or by participation in long-term success based outcomes from clinical trials.